Fisher & Paykel Healthcare Corporation Limited · NZX:FPH
Fisher & Paykel Healthcare — Shareholder Meeting (August 2026)
40 slides from Fisher & Paykel Healthcare's shareholder meeting presentation, Aug 25, 2026
Slide 1: News Release: 2026 Annual Shareholders' Meeting Speech and Presentation
News Release STOCK EXCHANGE LISTINGS: NEW ZEALAND (FPH), AUSTRALIA (FPH) 2026 Annual Shareholders’ Meeting Speech and Presentation Auckland, New Zealand, 25 August 2026 – Fisher & Paykel Healthcare Corporation Limited (NZX:FPH, ASX:FPH) has provided the Chair’s speech and CEO’s slide presentation fo
Slide 2: Address by Neville Mitchell, Board Chair
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED ANNUAL SHAREHOLDERS’ MEETING 25 AUGUST 2026 ADDRESS BY NEVILLE MITCHELL BOARD CHAIR Ladies and gentlemen, it is a privilege to address you again as Chair of your Board. In my address today, I will share the Board's perspective on the company's progress
Slide 3: Chair's address: culture, modern slavery, board composition
As the company continues to grow, maintaining our culture globally becomes increasingly important. The people of Fisher & Paykel Healthcare care deeply about patients, as well as their coworkers. They have a relentless desire to improve, value original thinking, approach their work with humility, an
Slide 4: Chair's address conclusion and CEO address introduction
continued to follow these issues closely and have met with experts in New Zealand and overseas to navigate them. In this regard, we acknowledge MFAT and the advice they provide us. We cannot control external events, but we can maintain our long-term view. This guides our decisions. The company’s suc
Slide 5: Annual Shareholders' Meeting August 2026
For personal use only Annual Shareholders' Meeting 1 25 August 2026
Slide 6: Your Board
Your Board For personal use only Neville Mitchell Lewis Gradon Mark Cross Anna Curzon Sir Michael Daniell Lisa McIntyre Graham McLean Cather Simpson 2
Slide 7: Agenda
Agenda • Chair’s Address For personal use only • Managing Director and Chief Executive Officer’s Address • Financial Statements • Resolutions • Voting • General Questions 3
Slide 8: Neville Mitchell, Board Chair
Neville Mitchell Board Chair For personal use only 4
Slide 9: NZ Campus - Building
For personal use only NZ Campus 1 - Building 5 28,000 m2 / 300,000 ft2
Slide 10: NZ Campus - Karaka
For personal use only NZ Campus 2 - Karaka Future second campus in South Auckland
Slide 11: For personal use only
Ajuo asn yjeuosijad 104
Slide 12: Your Board
Your Board For personal use only Neville Mitchell Lewis Gradon Mark Cross Anna Curzon Sir Michael Daniell Lisa McIntyre Graham McLean Cather Simpson 8
Slide 13: Anna Curzon, New director
Anna Curzon New director For personal use only 9
Slide 14: Margie Apa, Future Director
Margie Apa Future Director For personal use only 10
Slide 15: Neville Mitchell, Board Chair
Neville Mitchell Board Chair For personal use only 11
Slide 16: Lewis Gradon, Managing Director and CEO
Lewis Gradon Managing Director and CEO For personal use only 12
Slide 17: FY26 financial highlights
FY26 financial highlights Operating Revenue $2.31B 12% For personal use only (cc) Hospital Hardware 27% (cc) Gross Margin 63.7% 122bps Net Profit After Tax $468.5M 28% (cc) Constant currency growth rates 13
Slide 18: 10-year trends
10-year trends Revenue Net Profit After Tax FY26 FY26 $2.31B $468.5M For personal use only 12% 28% $2.5b $600m $500m $2.0b $400m $1.5b $300m $1.0b $200m $0.5b $100m $0.0b $0m 16 17 18 19 20 21 22 23 24 25 26 16 17 18 19 20 21 22 23 24 25 26 Constant currency growth rates 14
Slide 19: Dividends
Dividends Dividend history FY16 - FY26 For personal use only 60c FY26 Final Dividend 33cps 38% 50c 40c CPS (NZ cents) FY26 Total Dividend 52cps 22% 30c 20c 10-year DPS CAGR 12% 10c 0c 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Interim CPS Final CPS Total CPS 15
Slide 20: Global trade and world events
Global trade and world events For personal use only
Slide 21: FY27 first half outlook
FY27 first half outlook At 31 July exchange rates*, guidance assumptions for the first half of the 2027 financial year include a continuation of the current trading environment and result in: For personal use only • Operating revenue of approximately $1.24 billion • Net profit after tax of approxima
Slide 22: FY27 full year outlook
FY27 full year outlook At 31 July exchange rates*, our full year guidance is for: For personal use only • Operating revenue in the range of approximately $2.47 billion to $2.57 billion • Net profit after tax in the range of approximately $525 million to $565 million. The first half and full year net
Slide 23: Building momentum for the future
Building momentum for the future FY2021 FY2026 Change Comment For personal use only R&D spend averaging 10.6% of People in Research & Development 684 969 42% revenue over five years. Our global patent portfolio now Patents in the United States 381 768 102% numbers more than 4,500. People in Sales, M
Slide 24: Gross margin recovery
Gross margin recovery Our 5-year margin history 65% For personal use only 60% 55% 50% 45% FY22 FY23 FY24* FY25 FY26 Long-term gross margin target *Underlying gross margin excludes the product recall provision 20
Slide 25: Revenue growth since 2001
Revenue growth since 2001 Revenue in NZ$ millions by financial year Revenue (NZ$m) For personal use only $2,500 ~24 million patients $2.31 billion revenue $2,000 $1,500 $1,000 $500 $0 2001 2006 2011 2016 2021 2026 21
Slide 26: Neville Mitchell, Board Chair
Neville Mitchell Board Chair For personal use only 22
Slide 27: Financial statements
Financial statements • Opportunity for shareholders to ask any questions specifically on the financial statements, the auditor’s report or the company’s 2026 annual report. For personal use only • There will be an opportunity to ask any general questions once all items on the agenda have been consid
Slide 28: Resolutions
Resolutions 1. Election of Anna Curzon For personal use only 2. Auditor’s Remuneration 3. Directors’ Remuneration 4. Discretionary Long Term Variable Remuneration to Lewis Gradon 5. Issue of Performance Share Rights – North America 6. Issue of Share Options – North America 7. Issue of Employee Share
Slide 29: How to vote online
How to vote online For personal use only Help line Voting box Question box 25
Slide 30: Neville Mitchell, Board Chair
Neville Mitchell Board Chair For personal use only 26
Slide 31: Resolution 1: Election of Anna Curzon
Resolution 1: Election of Anna Curzon That Anna Curzon, who being eligible, offers herself for election, be elected as a For personal use only Director of the company. Click “Submit Vote” to lodge your vote. Need help? Call the MUFG Corporate Markets helpline 0800 200 220 27
Slide 32: Resolution 2: Auditor's Remuneration
Resolution 2: Auditor’s Remuneration That the Directors be authorised to fix the fees and expenses of PwC as the For personal use only company’s auditor. Click “Submit Vote” to lodge your vote. Need help? Call the MUFG Corporate Markets helpline 0800 200 220 28
Slide 33: Resolution 3: Directors' Remuneration
Resolution 3: Directors’ Remuneration That the maximum aggregate annual remuneration payable to non-executive For personal use only Directors be increased by NZ$350,000 from NZ$1,750,000 to NZ$2,100,000 (plus GST as appropriate). Click “Submit Vote” to lodge your vote. Need help? Call the MUFG Corpo
Slide 34: Resolution 4: Discretionary Long Term Variable Remuneration
Resolution 4: Discretionary Long Term Variable Remuneration That the grant of discretionary long term variable remuneration instruments to For personal use only Lewis Gradon, Managing Director and Chief Executive Officer, be approved. Click “Submit Vote” to lodge your vote. Need help? Call the MUFG
Slide 35: Resolution 5: Issue of Performance Share Rights
Resolution 5: Issue of Performance Share Rights That the Fisher & Paykel Healthcare Corporation Limited 2025 Performance For personal use only Share Rights Plan – North America be approved. Click “Submit Vote” to lodge your vote. Need help? Call the MUFG Corporate Markets helpline 0800 200 220 31
Slide 36: Resolution 6: Issue of Share Options
Resolution 6: Issue of Share Options That the Fisher & Paykel Healthcare Corporation Limited 2025 Share Option For personal use only Plan – North America be approved. Click “Submit Vote” to lodge your vote. Need help? Call the MUFG Corporate Markets helpline 0800 200 220 32
Slide 37: Resolution 7: Issue of Employee Share Rights
Resolution 7: Issue of Employee Share Rights That the Fisher & Paykel Healthcare Corporation Limited Employee Share For personal use only Rights Plan – North America be approved. Click “Submit Vote” to lodge your vote. Need help? Call the MUFG Corporate Markets helpline 0800 200 220 33
Slide 38: Neville Mitchell, Board Chair
Neville Mitchell Board Chair For personal use only 34
Slide 39: Questions
For personal use only 35 Questions Questions
Slide 40: Thank you for attending today's Annual Shareholders' Meeting
For personal use only Thank you for attending today’s Annual Shareholders' Meeting 36
Fisher & Paykel Healthcare — Shareholder Meeting (August 2026) on 6ix